Skip to content
CDMO SERVICES FOR VIRAL VECTORS & VACCINES

Producer Cell Line Development

Get the right cell line for production of your vector and virus! 

IN A NUTSHELL

Cell Lines for Viral Vector and Virus Production

In the rapidly advancing field of gene therapy and vaccine development, the production of viral vectors such as lentiviruses, adeno-associated viruses (AAV), adenoviruses, modified vaccinia Ankara (MVA), and other viruses is critical. Developing robust and efficient cell lines in-house for the production of these viral vectors offers significant advantages, especially when these cell lines are cultivated in suspension using chemically defined media. 
Virals Producer Cell line Dev
HOW WE WORK

Across Whole Viral Vectors GMP Life Cycle

GMP-Compliance

Capability and Scale

State-of-Art Technologies

Drug Product Filling

All on One Place

THE PLATFORMS BEHIND IT

Hek 293 Cell Line for Unparalleled Control

Duck Cell Line for the Production of MVA and Other Vaccine Candidates

Suspension Culture Systems for More Efficiency

Chemically Defined Media to Eliminate Variability

Our Promise To You

Growth Graph
 
High Yield in Suspension Culture

 

  • Suspension-adapted producer cells enable scalable, high-yield production in bioreactors 
  • This makes them ideal for large-scale viral vector and vaccine manufacturing

 

Asset 3
 
Consistency with Chemically Defined Medium
  • Growing producer cells in a chemically defined medium ensures a consistent and reproducible environment 
  • This helps control batch variability, improve process reliability, and ensure consistent viral vector potency 
Asset 11
 
Enhanced Safety and Compliance with GMP Grade Suspension Lines 
  • Suspension-adapted, fully characterized master and working cell banks (MCBs, WCBs) in chemically defined media meet rigorous safety and regulatory standards 
  • This supports robust production processes in essentially closed system

Elevate Your Candidate With The Right CDMO

Discover Related Services

Explore Viral Technologies

Explore Related Content

Header CDMO

Trends and Requirements in CDMO Projects for Biopharmaceuticals

Blog Post

Blog Image-09-1

Transponsons and Transposases: A Dynamic Duo in Genetic Engineering

Blog Post

COVER Process Intensification Blogpost-16by9 (1)-1

Investing in Efficiency: Benefits of Process Intensification in Upstream Processing

Blog Post

Interim Header Picture

A Success Story on Partnership - the Invisible Superpower in CDMO Projects

Blog Post

Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.